| Author: | Ramaswamy Govindan, Daniel Morgensztern | ISBN: | 9781496318435 |
| Publisher: | Wolters Kluwer Health | Publication: | April 3, 2015 |
| Imprint: | Wolters Kluwer Health | Language: | English |
| Author: | Ramaswamy Govindan, Daniel Morgensztern |
| ISBN: | 9781496318435 |
| Publisher: | Wolters Kluwer Health |
| Publication: | April 3, 2015 |
| Imprint: | Wolters Kluwer Health |
| Language: | English |
Get the latest, most reliable cancer management recommendations in the famous fast-access Washington Manual® outline format! Concise, clearly written sections on principles of oncology, site-specific diseases, and supportive therapy make The Washington Manual® of Oncology, 3rd Edition, an invaluable resource for the daily care of cancer patients. The Washington Manual® is a registered mark belonging to Washington University in St. Louis to which international legal protection applies. The mark is used in this publication by LWW under license from Washington University. Better understand innovative developments in oncology with new chapters on Genome Sequencing, Personalized Therapy, Endocrine Tumors, Myelodysplastic Syndromes, Anti-emesis and Survivorship. Focus on new ideas in the field thanks to a greater emphasis on molecular diagnosis, genome sequencing, and targeted therapies. Quickly locate key information in the appendices, such as body surface area, dose adjustments of chemotherapy agents in renal and hepatic failure, and online resources for oncologists. Benefit from proven treatment recommendations from the experts at Washington University in St. Louis – ideal for the busy third and fourth year student, resident, or clinician.
Get the latest, most reliable cancer management recommendations in the famous fast-access Washington Manual® outline format! Concise, clearly written sections on principles of oncology, site-specific diseases, and supportive therapy make The Washington Manual® of Oncology, 3rd Edition, an invaluable resource for the daily care of cancer patients. The Washington Manual® is a registered mark belonging to Washington University in St. Louis to which international legal protection applies. The mark is used in this publication by LWW under license from Washington University. Better understand innovative developments in oncology with new chapters on Genome Sequencing, Personalized Therapy, Endocrine Tumors, Myelodysplastic Syndromes, Anti-emesis and Survivorship. Focus on new ideas in the field thanks to a greater emphasis on molecular diagnosis, genome sequencing, and targeted therapies. Quickly locate key information in the appendices, such as body surface area, dose adjustments of chemotherapy agents in renal and hepatic failure, and online resources for oncologists. Benefit from proven treatment recommendations from the experts at Washington University in St. Louis – ideal for the busy third and fourth year student, resident, or clinician.
